AB0884-HPR PERSONALISED TREATMENT GOALS IN PATIENTS WITH IMMUNE MEDIATED INFLAMMATORY DISEASE
نویسندگان
چکیده
Background: Immune mediated inflammatory diseases (IMIDs) often have a chronic character and large impact on daily life of patients. In order to provide patient-centred care, insight in personal goals is key issue. Objectives: The aim this study was evaluate treatment patients with IMIDs over time. Methods: Patients were invited complete self-designed questionnaire about lifestyle, perceived care at their first visit our centre one year after referral. Clinical information collected through the electronic patient record system. Results: 41 (30%) 137 invited, completed both questionnaires. Participants had mean age 45.6 years (SD 13.4), N=35 (83%) female, disease duration 12.7 12.7). diagnosed connective tissue (CTD, n=19; 45%), antiphospholipid syndrome (APS, n=10; 24%), arthritis (n=7; 17%) psoriasis 17%). We identified six categories goals: related, functioning, emotional wellbeing. Figure 1 shows reported baseline follow-up. Most frequently mentioned related disease, lifestyle functioning. At follow-up we observed vast increase psychological wellbeing (from 5% 16%). APS chose lifestyle-related more than other (RR=3.2; p=0.015). CTDs related-goals less (RR=0.4; p=0.002). did not report significant progress reaching Likert scale 1-10. However, 90% 83% follow-up, that provided addressing issues they personally prioritized. Conclusion: IMID patients’ most frequent relate activity, change during treatment. Better understanding can help physicians providing targeted personalised medicine. 1. themes Acknowledgements: researchers would like thank all participating acknowledge UMC Utrecht research program Infection Immunity for supporting initiative. Disclosure Interests: None declared
منابع مشابه
modern surgical techniques in treatment of patients with cleft lip & cleft palate
چکیده ندارد.
15 صفحه اولCardiovascular disease in immune-mediated inflammatory diseases
To analyze in several immune-mediated inflammatory diseases (IMIDs) the influence of demographic and clinical-related variables on the prevalence of cardiovascular disease (CVD), and compare their standardized prevalences.Cross-sectional study, including consecutive patients diagnosed with rheumatoid arthritis, psoriatic arthritis, psoriasis, systemic lupus erythematosus, Crohn disease, or ulce...
متن کاملAuto-antibodies in Patients with Inflammatory Bowel Disease Unclassified
Background: Inflammatory bowel disease unclassified (IBDU) is considered to be an aberrant immune response with loss of tolerance to many antigens. Objective: This paper tries to address whether there is any value to test for auto-antibodies in such patients. Methods: 60 patients with inflammatory bowel disease unclassified participated in the study. Auto-antibodies to nuclear antigen, intestin...
متن کاملReview Vaccinations in patients with immune-mediated inflammatory diseases
Patients with immune-mediated inflammatory diseases (IMID) such as RA, IBD or psoriasis, are at increased risk of infection, partially because of the disease itself, but mostly because of treatment with immunomodulatory or immunosuppressive drugs. In spite of their elevated risk for vaccine-preventable disease, vaccination coverage in IMID patients is surprisingly low. This review summarizes cu...
متن کاملVaccinations in patients with immune-mediated inflammatory diseases
Patients with immune-mediated inflammatory diseases (IMID) such as RA, IBD or psoriasis, are at increased risk of infection, partially because of the disease itself, but mostly because of treatment with immunomodulatory or immunosuppressive drugs. In spite of their elevated risk for vaccine-preventable disease, vaccination coverage in IMID patients is surprisingly low. This review summarizes cu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of the Rheumatic Diseases
سال: 2021
ISSN: ['1468-2060', '0003-4967']
DOI: https://doi.org/10.1136/annrheumdis-2021-eular.259